In a large US healthcare network, invasive fungal infection (IFI) was not uncommon, affected a broad spectrum of patients, and was associated with high crude mortality, a recent study found. All records in the Intermountain Healthcare Enterprise Data Warehouse from 2006-2015 were queried for clinical data associated with IFI. Resulting data were overlaid in 124 different combinations to identify high-probability IFI cases. Researchers found:
- 3,374 IFI occurred in 3,154 patients.
- Mean incidence was 27.2 cases per 100,000 patients per year with a mean annual increase of 0.24 cases/100,000 patients.
- Candidiasis was the most common IFI (55%).
- Median age was 55 years; pediatric cases account for 13%.
- Lymphopenia preceded IFI in 22.1% of patients.
- Hospital admission occurred in 76.2% of patients, with median length of stay of 16 days.
- All-cause mortality was 17.0% at 42 days and 28.8% at 1 year.
Webb BJ, Ferraro JP, Rea S, Stephanie Kaufusi, Goodman BE, Spalding J. Epidemiology and clinical features of invasive fungal infection in a U.S. Healthcare Network. [Published online ahead of print July 31, 2018]. Open Forum Infect Dis. doi:10.1093/ofid/ofy187.
This Week's Must Reads
Must Reads in Mycoses
Variability in Antifungal Utilization in the US, BMC Infect Dis; ePub 2018 Oct 3; Stultz, et al
Clinical Features of Invasive Fungal Infection , Open Forum Infect Dis; ePub 2018 Jul 31; Webb, et al
Toxocara Seroprevalence in the US & Risk Factors, Clin Infect Dis; ePub 2017 Sep 4; Liu, et al
Mucormycosis-Related Hospitalization Trends in US, Open Forum Infect Dis; ePub 2017 Jan 13; Vallabhaneni, et al
Mucormycosis-Related Hospitalizations in the US, BMC Infect Dis; ePub 2016 Dec 1; Kontoyiannis, et al